Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v9-EN
Language French English
Date Updated 2017-12-01 2017-12-01
Drug Identification Number 02137534 02137534
Brand name MYLAN-ALPRAZOLAM MYLAN-ALPRAZOLAM
Common or Proper name ALPRAZOLAM ALPRAZOLAM
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ALPRAZOLAM ALPRAZOLAM
Strength(s) 0.25MG 0.25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT, 1000BT 100BT, 1000BT
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-02-01 2021-02-01
Actual discontinuation date
Remaining supply date 2021-02-01 2021-02-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments